DTC
ORKA

Deep Track Capital’s Oruka Therapeutics ORKA Stock Holding History

Deep Track Capital’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$183M Sell
1,926,000
-108,203
-5% -$7.21M 2.67% 13
2026
Q1 		$99.8M Sell
2,034,203
-127,307
-6% -$4.42M 1.63% 18
2025
Q4 		$65.5M Sell
2,161,510
-493,271
-19% -$13.7M 1.17% 22
2025
Q3 		$51.1M Buy
2,654,781
+735,983
+38% +$10.9M 1.42% 26
2025
Q2 		$21.5M Buy
1,918,798
+474,089
+33% +$4.94M 0.69% 37
2025
Q1 		$14.8M Buy
1,444,709
+694,709
+93% +$8.66M 0.48% 44
2024
Q4 		$14.5M Sell
750,000
-485,187
-39% -$11.8M 0.54% 43
2024
Q3 		$30.3M Buy
+1,235,187
New +$43M 0.96% 32

Other funds holding ORKA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Deep Track Capital's ORKA Position: Q2 2026 in Review

Deep Track Capital reduced its Oruka Therapeutics (ORKA) stake by 5.3% in Q2 2026, selling an estimated $7.21M and leaving 1,926,000 shares worth $183M. The position accounts for 2.67% of the portfolio, ranked #13.

Deep Track Capital first reported a position in ORKA in Q3 2024 and has held it in 8 quarters since. 256 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Deep Track Capital held 1,926,000 shares of Oruka Therapeutics worth $183M as of Q2 2026.
  • Deep Track Capital sold 108,203 Oruka Therapeutics shares in Q2 2026, an estimated $7.21M.
  • Oruka Therapeutics made up 2.67% of Deep Track Capital's portfolio in Q2 2026, its #13 holding.
  • Deep Track Capital first reported a position in Oruka Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 256 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.